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Two cell response pathways, Toll-like receptor (TLR) and Notch, conserved from Drosophila to mammals are
well characterized for distinct roles in innate immunity and cell development, respectively. In this issue of
Immunity, Hu et al. (2008) describe and characterize the direct cooperation of these two pathways.The Toll-like receptors (TLRs) are a sens-
ing system of the innate immune family of
pattern-recognition receptors that re-
spond to infectious microbes and endog-
enous ligands to protect the host from
infection and other diseases. These re-
ceptors are key factors in orchestrating
the innate and subsequent adaptive im-
mune response. The TLRs signal by en-
gagement of TIR-containing adaptors, re-
cruitment of additional adaptors and
kinases, including IKKa, IKK3, Tbk, and
MAP kinases, and by activation of gene
transcriptional programs mediated by
the transcription factors NFkB, IRFs, fos,
and jun. The effector molecules of these
targets include proinflammatory cyto-
kines such as IL1, TNFa, IL6, type I (a
and b), and type II (g) interferons (IFNs)
and immunoregulatory cytokines IL12 and
IL10. Appropriate regulation of this re-
sponse results in resolution of primary
inflammation, but inappropriate response
can lead to sepsis, chronic inflammation,
autoimmune disease, and cancer. Many
negative regulators of the TLR system
have been described in extracellular,
plasma membrane, intracellular, and
nuclear compartments that impact at
many levels of signal transduction (Lang
and Mansell, 2007). In this issue of
Immunity, Hu et al. (2008) demonstrate
that TLR and Notch signal transduction
pathways cooperate to modulate canoni-
cal Notch target genes, which in turn feed
back to negatively regulate a subset of
TLR responsive genes that regulate the
innate sculpting of adaptive immune
responses.
The Notch signaling system, like the
TLRs, is conserved fromDrosophila to hu-
mans and regulates cell differentiation,
proliferation, and survival (Bray, 2006).
Notch pathways play an important role in
embryonic development, T cell develop-ment and function, and in disease pro-
cesses including carcinogenesis and
autoimmunity. In mammals there are four
Notch receptors (1 to 4) and five Notch
ligands (Jagged 1, Jagged2, Delta-like 1
[DLL1], DLL3, and DLL4). Notch-ligand
binding to its cognate receptor leads first
to ADAM protease cleavage of the extra-
cellular domain of the receptor, then
g-secretase cleavage of the Notch intra-
cellular domain (NICD). The NICD is trans-
located to the nucleus and binds to RBP-J
that displaces transcriptional repressors
and assembles a transcriptional activa-
tion complex that drives the transcription
of Notch-pathway target genes (Figure 1).
Two well-characterized Notch inducible
genes are Hes1 and Hey1, basic helix-
loop-helix transcriptional repressors that
function as feedback inhibitors of Notch
signaling.
In the immune system, the role of Notch
signaling in the development and function
of T cells, macrophage, NK cells and den-
dritic cells has recently been a hot topic.
Notch regulates blood cell homeostasis
in Drosophila (Krzemien´ et al., 2007),
T cell differentiation in the thymus (Jenkin-
son et al., 2006) and interactions between
Notch signaling andGATA3 determine the
balance of T helper 1 (Th1) and Th2 cells
(Amsen et al., 2007). In the disease set-
ting, Notch signaling via the transcription
factor RBP-J integrates with CREB1 to
promote T cell cytotoxicity (Maekawa
et al., 2008), it regulates outcomes of air-
way inflammation (Okamoto et al., 2008)
and Notch signaling components includ-
ing receptors and ligands are reportedly
induced by TLR activation (Palaga et al.,
2008). However, the mechanism underly-
ing the latter observation and other as-
pects of Notch involvement in inflamma-
tory disease has been unclear. Here, Hu
et al. (2008) identify a direct cooperativityImmunity 29, Nbetween Notch and TLR signaling, defin-
ing the mechanism of this cooperation
and how it impacts TLR-driven immune
regulation.
This study developed from an examina-
tion of the interaction between the potent
immunoregulatory cytokine IFN-g, a prod-
uct of activated T cells, NK cells, or NKT
cells, and its ability to modulate macro-
phage responses to TLR ligands. Among
the IFN-g-suppressed subsets of TLR-
inducible genes were the canonical Notch
targets Hes1 and Hey1. The TLR induc-
tion of these genes was demonstrated
as being independent of Notch ligands
or receptors, and optimal expression re-
quired synergism between the TLR and
Notch intracellular signal transduction
pathways.
Hu et al. (2008) demonstrate that TLRs
directly induce expression of canonical
Notch target genesHES1 andHEY1 in hu-
man-blood-derived macrophages, with-
out induction of NICD or Notch ligands
(Figure 1). Through an elegant series of
experiments using chemical inhibitors,
RNAi knockdown, and cells from gene-
deficient mice, the authors demonstrated
that there is a subset of TLR-inducible
genes that were dependent on Notch sig-
naling via RBP-J. These include HES1,
HEY1, IL7R, and IL2RA. Importantly, this
regulation is not a global effect on TLR
signaling, given that there is no effect on
IL1b expression. Although these afore-
mentioned effects are independent of
Notch ligands, it is important to note that
others have reported induction of Notch
ligands and receptors at later time points
after TLR-ligand engagement than the
times examined in the study by Hu et al.
(2008). Thus at these later time points,
a secondary, ligand-mediated input of
Notch signaling would add to the Notch
impact on TLR responses.ovember 14, 2008 ª2008 Elsevier Inc. 663
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target-gene induction was shown to re-
quire not only NCID expression but also
canonical TLR signaling. Experiments
using small-molecule inhibitors and RNAi
identified TLR-mediated IKKb and p38
MAP kinase pathways in the transcrip-
tional regulation of HES1 expression.
Because this gene is not known to be a
classic NFkB target gene, and because
p38 and IKKb have been associated with
histone H3 recruitment to promoters, the
authors demonstrated, using chromatin
immunoprecipitation, that serine phos-
phorylated histone H3 is indeed recruited
to the hes1 promoter after TLR stimulation.
This study also describes an intricate
activation and inhibition loop of Notch-
TLR signaling. First, the conditional dele-
tion of RBP-J in myeloid cells partially
protected mice from LPS toxicity and was
accompanied by decreased serum con-
centrations of proinflammatory cytokines
TNFa and IL6. This in vivo result is consis-
tent with in vitro data on RBP-J regulation
of TLR-induced IL-12 family cytokines
and IL-6. Further investigation identified
in the IL-6 promoter a critical RBP-J-bind-
ing site that regulated TLR-activation of
IL-6 expression. In addition to this direct
activation of TLR responses by Notch sig-
naling components, Hu et al. (2008) also
describe an indirect feedback inhibition
of TLR-induced IL-6 and IL-12 by the
RBP-J targets Hes1 and Hey1. With
bone marrow chimeras, Hey1 deficiency
in haemopoietic cells was demonstrated
to increase peritoneal inflammation in-
duced by TLR2 ligand. Hey1 deficiency
in cells does not markedly alter expres-
sion of TNF or IL-10, but IL -6 and IL-12
are elevated. Thus, Hey1 functions as
a negative regulator of the IL-6 and IL-
12. Hey1 was shown to directly suppress
IL-6 reporter transcription, not via the N
box but via an E box adjacent to the
RBP-J-binding element. Although Hes1
was more difficult to examine because
of the lethality of gene-deficient mice,
the authors derived fetal-liver hemopoi-
etic cells from Hes1-deficient mice whose
macrophages produced higher amounts
of IL-6, and these results were corrobo-
rated in reporter assays. Once again the
outcome of one signal transduction path-
way (Notch) on another (TLR) is a question
of balance, in this case between the
potential of Notch pathway to activate
TLR-driven cytokines via RBP-J and the
repression by the RBP-J targets Hes1
and Hey1.
The Notch signaling pathway in macro-
phages is inhibited by IFN-g. Interestingly,
the mechanism of IFN-g inhibition of Hes1
followed different kinetics from that of
Hey1, suggesting different mechanisms
of IFN-g inhibited RNA polII recruitment
to the Hes1 promoter. However, IFN-g
Figure 1. TLR Ligands Activate the Canonical Notch Signaling Pathway in Addition to the
Well-Known Pathways of NF-kB p65 and p50 Subunits, IRF3, IRF5, and IRF7, and fos and jun
Pathways
TLR activation of RBP-J occurs via MAP kinase and IKKb, and it is independent of Notch ligand but
requires the NICD. RBP-J drives transcription of IL-6 directly. However, RBP-J also drives the Notch target
genes HES1 and HEY1, which suppress IL-6 expression and TLR-driven inflammation.664 Immunity 29, November 14, 2008 ª2008 Elsevier Inc.does not affect Notch-receptor expres-
sion but decreases intracellular amounts
of NICD2. It will be important to determine
how this IFN-g-mediated suppression of
NICD occurs because it may have func-
tional implications for the many immuno-
regulatory effects of this cytokine and
have relevance to the known Notch ef-
fects on T cell development and function.
Thus, Hu et al. (2008) elucidate a mech-
anism whereby Notch and TLR pathways
reciprocally regulate their respective
pathways. In the context of TLR signaling,
the Notch pathway provides an alterna-
tive negative regulation to those already
elucidated—in this case one that may be
operational during stages of cell develop-
ment. This adds to the number of signal-
ing pathways including NLRs (nucleo-
tide-binding domain and leucine-rich
repeat containing gene family), C-type
lectins, glucocorticoids, and cytokines
that impact on the TLR signaling path-
ways, either positively or negatively
(O’Neill, 2008). It will be important to de-
termine whether these reciprocal regula-
tion pathways identified in this paper are
restricted to particular cell types or are
broadly operational.
The host response system including the
TLRs is emerging to have a role in re-
sponding to endogenous ligands such
as those occurring during regulated cell-
death programs crucial not only in host
defense but also in homeostasis and de-
velopment, as well as the initiation of dis-
ease such as autoimmunity. The Notch-
TLR reciprocal regulation provides new
areas of investigation in these contexts.
Furthermore, from the Notch perspective,
an impact of the TLR pathwaymight imply
a potential role for this ‘‘host defense’’
system in the regulation of cell develop-
ment. Perhaps this is not surprising con-
sidering that regulating cell death is
sometimes an important defense mecha-
nism for a host under attack from a patho-
gen. From a disease perspective, the
Notch-TLR interaction provides an addi-
tional focus for exploring the importance
of this interaction in chronic diseases
such as autoimmunity, in chromic inflam-
mation as it occurs in the lung, or in pro-
moting carcinogenesis. Furthermore,
given the rather selective nature of the
subset of signals regulated by the Notch
pathway, therapeutic targeting of this as-
pect of the TLR response may be of ben-
efit in the appropriate setting.
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Together with the pore-forming protein
perforin, the family of granule-bound
serine proteases known as granzymes
forms an antiviral arsenal central to the
function of cytotoxic T lymphocyte
(CTL) and natural killer (NK) cells. The
prevailing view is that perforin facilitates
entry of granzymes into the cytoplasm
of a target cell, where they access their
substrates to trigger cell death (Vosko-
boinik et al., 2006). Humans and rodents
have three granzyme subfamilies en-
coded on distinct chromosomal loci: (1)
granzymes A and K have trypsin-like ac-
tivity; (2) granzyme M cleaves after un-
branched hydrophobic residues; and (3)
human granzymes B and H and rodent
granzymes B through G have chymotryp-
sin-like activity. Although there is no
doubt that granzyme B plays an impor-
tant role in inducing apoptosis, and it is
generally accepted that granzyme A can
trigger a distinct nonapoptotic form of
cell death, the cytotoxicity of other gran-
zymes is less certain. Over the years,
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ies have dealt with these topics, particu-
larly of late.
Although amolecular or cellular mecha-
nism is not comprehensively defined,
Metkar et al. (2008) now show that gran-
zyme A secreted by CTLs promotes the
release of IL-1b and other inflammatory
cytokines from antigen-presenting cells
such as primary mouse macrophages
in vitro. It is inferred from the data that
granzyme A enters activated monocytes
or macrophages to potently induce in-
flammatory cytokine release. Release
can be blockedwith a caspase-1 inhibitor,
suggesting that the production of active
IL-1b does not result from direct process-
ing of pro-IL-1bbygranzymeA. The in vivo
relevance of these findings is indicated by
the fact that mice deficient for granzyme A
are partially resistant to lipopolysaccha-
ride (LPS)-induced toxic shock, which is
known to be mediated by the release
of proinflammatory cytokines including
IL-1b. However, these results seem to be
confounded by the unexplained and
conflicting observations that granzyme
B-deficient mice are also resistant to
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LPS, whereas granzyme A and B doubly-
deficient mice are as sensitive as wild-
type. It is difficult to reconcile these
results, and we are also left to ponder
whether granzyme-mediated inflamma-
tion is perforin dependent.
A key question posed by Metkar et al.
(2008) is whether granzyme A plays any
significant role in target cell death. The
investigators use a variety of assays but
fail to reproduce the cytotoxic activity of
granzyme A other than at very high con-
centrations, thereby challenging the view
that cell-death induction is an important
and intrinsic function of this protease. To
put these findings into context, Hayes
et al. (1989) were the first to describe
synergy between granzymes and perforin
leading to apoptosis. Soon after, three dif-
ferent DNA-fragmenting activities within
rat CTL granules were identified as gran-
zyme A (fragmentin-1), granzyme B (frag-
mentin-2), and granzyme K (fragmentin-3)
(Shi et al., 1992). Further elegant studies
demonstrated that expression of perforin
in RBL-2H3 cells enables killing via necro-
sis, but that coexpression with granzymes
November 14, 2008 ª2008 Elsevier Inc. 665
